| Literature DB >> 31908407 |
C Lommatzsch1, K Rothaus1, J M Koch1, C Heinz1,2, S Grisanti3.
Abstract
PURPOSE: To compare papillary and macular vessel density (VD), as measured by optical coherence tomography angiography (OCTA), in eyes with primary open-angle glaucoma (POAG), normal-tension glaucoma (NTG) and exfoliation glaucoma (XFG).Entities:
Keywords: OCT angiography; blood flow; glaucoma entities; vessel density
Year: 2019 PMID: 31908407 PMCID: PMC6925548 DOI: 10.2147/OPTH.S230192
Source DB: PubMed Journal: Clin Ophthalmol ISSN: 1177-5467
Demographic and Ocular Characteristics of the Study Population
| POAG | NTG | XFG | p-Valuea | |
|---|---|---|---|---|
| Number of eyes (n) | 40 | 19 | 21 | |
| Age (years) | 61.45±14.33 | 57.32±13.82 | 70.09±6.81 | 0.00595 |
| Time since first diagnosis of glaucoma (months) | 134.29±116.62 | 40.0±53.84 | 73.88±48.16 | 0.0026 |
| IOP (mmHg) | 16.45±4.67 | 14.05±3.58 | 18.05±7.90 | 0.0763 |
| Refractive error (dpt) | −0.59±2.0 | −1.86±2.46 | 0.24±1.95 | 0.0105 |
| Pseudophakia (n) | 7 | 1 | 4 | 0.391 |
| Cup:disc ratio (mean ± SD) | 0.54±0.20 | 0.66±0.12 | 0.61±0.16 | 0.0404 |
| Mean deviation in visual field (dB) | −3.79±5.74 | −6.5±5.67 | −4.66±8.12 | 0.0049 |
| Antiglaucomatous eye drops (number of active pharmaceutical ingredients) | 2.32±1.54 | 1.63±1.49 | 2.52±1.66 | 0.167 |
| GCC total (µm) | 86.09±10.51 | 78.74±15.44 | 79.56±11.99 | 0.0445 |
| RNFL average (µm) | 79.73±13.66 | 76.37±17.47 | 77.14±15.04 | 0.671 |
Abbreviations: POAG, primary open-angle glaucoma; XFG, exfoliation glaucoma; NTG, normal-tension glaucoma; GCC, ganglion cell complex; RNFL, retinal nerve fiber layer.
Values expressed as mean ± standard deviation (a1-way ANOVA).
OCTA Results for ONH Vessel Density in the RPC Layer
| Segmentation RPC | POAG | NTG | XFG | p-Valuea | Differences Between the Three Groupsb |
|---|---|---|---|---|---|
| SSI | 57.0 (41.0;72.0) | 56.0 (40.0;71.0) | 50.0 (42.0;74.0) | 0.09 | |
| wpVD (%) | 47.55 (27.8;58.9) | 48.11 (25.2;56.4) | 45.89 (29.7;52.2) | 0.22 | |
| iVD (%) | 26.41 (6.9;55.5) | 22.92 (7.3;36.0) | 23.93 (7.06;38.1) | 0.07 | |
| ppVD avg (%) | 57.35 (34.1;68.5) | 58.73 (32.36;70.5) | 54.41 (36.8;61.9) | 0.08 | |
| ppVD nas (%) | 53.15 (31.1;66.6) | 56.59 (23.4;66.14) | 52.42 (32.2;60.5) | 0.04 | |
| ppVD infnas (%) | 56.09 (30.4;72.1) | 65.86 (30.6;71.3) | 54.2 (32.8;66.6) | 0.017 | NDG vs PEX and POAG |
| ppVD inftemp (%) | 59.5 (31.9;73.2) | 62.5 (30.2;75.8) | 51.2 (38.7;66.8) | 0.11 | |
| ppVD suptemp (%) | 60.2 (27.5;76.7) | 59.2 (28.4;79.8) | 53.2 (28.5;71.2) | 0.14 | |
| ppVD supnas (%) | 53.8 (30.8;64.9) | 57.1 (25.1;72.6) | 52.5 (23.9;64.5) | 0.26 | |
| ppVD temp (%) | 59.9 (35.5;69.9) | 58.5 (39.6;70.7) | 58.4 (31.4;64.9) | 0.39 |
Abbreviations: POAG, primary open-angle glaucoma; XFG, exfoliation glaucoma; NTG, normal-tension glaucoma; SSI, signal strength index; RPC, radial peripapillary capillary layer; wpVD, whole papillary vessel density; iVD, inside disc vessel density; ppVD, peripapillary vessel density.
All values expressed as median and range (Min; Max). aKruskall–Wallis test; bpost-hoc analysis between the groups (Conover).
OCTA Results for ONH Vessel Density in the NH Layer
| Segmentation NH | POAG | NTG | XFG | p-Valuea | Differences Between the Three Groupsb |
|---|---|---|---|---|---|
| SSI | 57.0 (41.0;72.0) | 56.0 (40.0;71.0) | 50.0 (42.0;74.0) | 0.09 | |
| wpVD (%) | 49.9 (28.8;58.9) | 50.7 (26.3;57.3) | 46.9 (34.3;54.7) | 0.09 | |
| iVD (%) | 47.3 (30.8;57.5) | 45.7 (31.7;54.5) | 41.9 (32.7;52.2) | 0.21 | |
| ppVD avg(%) | 54.9 (33.3;63.3) | 56.8 (31.1;64.9) | 52.3 (36.8;59.8) | 0.07 | |
| ppVD nas (%) | 51.2 (32.9;63.4) | 54.3 (23.3;62.8) | 49.1 (29.1;59.4) | 0.08 | |
| ppVD infnas (%) | 54.9 (28.6;68.0) | 60.9 (29.0;69.2) | 52.4 (30.4;63.9) | 0.04 | NDG vs PEX |
| ppVD inftemp (%) | 58.6 (33.2;70.2) | 56.7 (28.4;71.8) | 52.5 (36.7;66.7) | 0.16 | |
| ppVD suptemp (%) | 57.3 (28.4;71.5) | 53.7 (36.5;74.2) | 51.3 (28.6;65.9) | 0.13 | |
| ppVD supnas (%) | 53.0 (31.1;63.4) | 56.4 (22.8;68.3) | 51.3 (16.5;67.6) | 0.21 | |
| ppVD temp (%) | 55.9 (26.6;64.4) | 51.7 (36.6;64.2) | 53.6 (35.3;59.5) | 0.45 |
Abbreviations: POAG, primary open-angle glaucoma; XFG, exfoliation glaucoma; NTG, normal-tension glaucoma; SSI, signal strength index; RPC, radial peripapillary capillary layer; wpVD, whole papillary vessel density; iVD, inside disc vessel density; ppVD, peripapillary vessel density.
All Values Expressed as Median and Range (Min; Max). aKruskall–Wallis test; bpost-hoc analysis between the groups (Conover).
OCTA (AngioVue™) Parameters for Macular VD Segmentation of the Superficial Layer (SL)
| Segmentation SL | POAG | NTG | XFG | p-Valuea | Differences Between the Three Groupsb |
|---|---|---|---|---|---|
| SSI | 56.5 (41.0;74.0) | 55.0 (41.0;73.0) | 56.0 (42.0;67.0) | 0.98 | |
| wmVD (%) | 42.3 (30.7;51.8) | 41.4 (29.8;51.8) | 41.4 (34.8;44.5) | 0.51 | |
| fVD (%) | 32.3 (19.2;43.8) | 28.4 (21.2;45.6) | 30.7 (19.5;37.4) | 0.08 | |
| pmVD avg (%) | 45.9 (34.1;56.5) | 45.1 (37.7;54.1) | 44.3 (39.8;51.6) | 0.61 | |
| pmVD temp (%) | 45.6 (37.1;55.3) | 46.1 (37.8;56.1) | 45.6 (36.4;52.1) | 0.83 | |
| pmVD sup (%) | 46.7 (27.9;56.8) | 45.4 (35.3;56.4) | 45.1 (35.8;52.1) | 0.22 | |
| pmVD nasal (%) | 45.9 (36.8;55.9) | 45.8 (36.8;54.8) | 44.5 (37.2;54.9) | 0.77 | |
| pmVD inf (%) | 44.8 (33.3;59.4) | 44.7 (31.1;59.0) | 44.6(33.4;51.1) | 0.78 |
Abbreviations: POAG, primary open-angle glaucoma; XFG, exfoliation glaucoma; NTG, normal-tension glaucoma; SSI, signal strength index; wmVD, whole macular vessel density; fVD, foveal vessel density; pmVD, perimacular vessel density.
All values expressed as median and range (Min; Max). aKruskall–Wallis test; bpost-hoc analysis between the groups (Conover).
OCTA (AngioVue™) Parameters for Segmentation for Macular VD of the Deep Layer (DL)
| Segmentation DL | POAG | NTG | XFG | p-Valuea | Differences Between the Three Groupsb |
|---|---|---|---|---|---|
| SSI | 56.5 (41.0;74.0) | 55.0 (41.0;73.0) | 56.0 (42.0;67.0) | 0.98 | |
| wmVD (%) | 49.6 (433.2;58.9) | 49.3 (33.3;61.8) | 50.1 (39.6;56.1) | 0.97 | |
| fVD (%) | 31.3 (19.2;46.9) | 26.2 (15.9;45.0) | 29.8 (16.5;37.8) | 0.27 | |
| pmVD avg (%) | 54.8 (42.6;63.5) | 54.1 (41.6;66.5) | 53.6 (42.7;66.5) | 0.65 | |
| pmVD temp (%) | 53.8 (40.6;67.4) | 51.6 (39.9;66.8) | 52.6 (41.1;59.5) | 0.54 | |
| pmVD sup (%) | 57.1 (33.0;65.6) | 54.8 (39.8;68.0) | 55.2 (35.2;59.5) | 0.50 | |
| pmVD nasal (%) | 53.7 (38.7;63.7) | 55.8 (35.4;65.5) | 52.9 (38.9;64.1) | 0.66 | |
| pmVD inf (%) | 55.7 (40.4;63.2) | 54.3 (40.5;67.1) | 54.1 (41.9;61.4) | 0.75 |
Abbreviations: POAG, primary open-angle glaucoma; XFG, exfoliation glaucoma; NTG, normal-tension glaucoma; SSI, signal strength index; wmVD, whole macular vessel density; fVD, foveal vessel density; pmVD, perimacular vessel density.
All values expressed as median and range (Min; Max). aKruskall–Wallis test; bpost-hoc analysis between the groups (Conover).